Comparison of clinical manifestations, treatment and outcomes between persistent and nonpersistent bloodstream infection (BSI) in infants hospitalized in the neonatal intensive care unit.

All data were expressed as number (percentage %), unless indicated otherwise; WBC: white blood cell; NTISS: Neonatal Therapeutic Intervention Scoring System; IQR: interquartile range; HFOV: high frequency oscillatory ventilator; CVC: central venous catheter&CRP normal range: *Infectious complications were defined as a newly infectious focus or persistent organ dysfunction which occurred within one week and directed related to bloodstream infection, but not concurrently at onset of bloodstream infection#For 74 neonates with persistent BSI and 641 neonates without persistent BSIComparison of clinical manifestations, treatment and outcomes between persistent and nonpersistent bloodstream infection (BSI) in infants hospitalized in the neonatal intensive care unit.除非另有说明，所有数据均以例数（百分比）形式报告。白细胞（white blood cell, WBC）、新生儿治疗干预评分系统（Neonatal Therapeutic Intervention Scoring System, NTISS）、四分位距（interquartile range, IQR）、高频振荡呼吸机（high frequency oscillatory ventilator, HFOV）、中心静脉导管（central venous catheter, CVC）；C反应蛋白（C-reactive protein, CRP）正常参考范围：*感染并发症定义为1周内新发感染病灶或持续性器官功能障碍，与血流感染直接相关，但并非与血流感染发作同时出现。#本研究纳入74例持续性血流感染患儿与641例非持续性血流感染患儿，旨在比较新生儿重症监护病房住院患儿持续性与非持续性血流感染（bloodstream infection, BSI）的临床表现、治疗方案及结局。